Biotech · Private company · New York, NY, US
Foli Bio Inc.
Track this companyFree. Adds Foli Bio Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Development of fecal exfoliome sequencing as a multi-omics approach for gut health managementFiscal year 2026 · $399.9KNIH RePORTER 1R43HG014430-01A1 · fetched Nov 12, 2026
- Non-invasive exfoliome platform to accelerate treatment for gastrointestinal disordersFiscal year 2024 · $292.4KNIH RePORTER 1R43DK141382-01 · fetched Nov 12, 2026